Brittany Huynh

ORCID: 0009-0008-7505-9206
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Adolescent and Pediatric Healthcare
  • Pregnancy and Medication Impact
  • Venous Thromboembolism Diagnosis and Management
  • Atrial Fibrillation Management and Outcomes
  • Systemic Lupus Erythematosus Research
  • Food Security and Health in Diverse Populations
  • Blood Pressure and Hypertension Studies
  • Cardiac Arrhythmias and Treatments
  • Child and Adolescent Health
  • Reproductive Health and Contraception
  • Primary Care and Health Outcomes
  • Healthcare Policy and Management
  • Reproductive System and Pregnancy

Indiana University – Purdue University Indianapolis
2020-2025

University School
2024

Indiana University School of Medicine
2020-2024

Indiana University
2023-2024

University of California, San Francisco
2022-2023

Abstract Background The purpose of this study was to identify reproductive health knowledge gaps and topics that concern adolescent young adult (AYA) women with pediatric rheumatic diseases their parents. Methods Data collection occurred in two cohorts. In the first cohort, (15–20 years old) pediatric-onset conditions parents were recruited from a single, academic rheumatology center. second (18–25 national conference for families diseases. This resulted 20 adolescents adults (18.3 ± 2.4...

10.1186/s12969-020-00460-7 article EN cc-by Pediatric Rheumatology 2020-08-17

Non-Hispanic Black men experience a disproportionate rate of morbidity and mortality from hypertension, cardiovascular disease, other chronic conditions in the United States. Studies have demonstrated efficacy community-based health outreach settings not traditionally utilized for care. Understanding how potential future participants view care services nontraditional is necessary step to ascertain success these interventions real world. Our study objective was explore preferences male...

10.1089/heq.2023.0157 article EN cc-by Health Equity 2023-12-01

Background: There are no clear dosing recommendations when using apixaban for venous thromboembolism (VTE) treatment in patients with severe renal disease; clinical trials excluded a creatinine clearance (CrCl) less than 25 mL/min or on dialysis. This study compares bleeding rates disease taking standard versus reduced dose VTE treatment.Materials and Methods: was multicenter, retrospective cohort at four large academic medical centers electronic records between January 1, 2013, August 31,...

10.2139/ssrn.4193838 article EN SSRN Electronic Journal 2022-01-01
Coming Soon ...